Venture Visionary Partners LLC Has $1.06 Million Stake in Danaher Corporation $DHR

Key Points

• Venture Visionary Partners LLC reduced its stake in Danaher Corporation by 42.6% during Q1, holding 5,169 shares valued at $1.06 million.
• Several institutional investors, including Banco Bilbao Vizcaya Argentaria S.A. and Berkshire Asset Management LLC PA, have increased their stakes in Danaher, reflecting a strong interest in the company among large investors.
• Danaher recently reported earnings of $1.80 per share for Q2, surpassing estimates and showing an increase in revenue, with analysts maintaining a consensus rating of "Moderate Buy" and an average target price of $247.61.

Venture Visionary Partners LLC trimmed its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 42.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,169 shares of the conglomerate's stock after selling 3,837 shares during the period. Venture Visionary Partners LLC's holdings in Danaher were worth $1,060,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Banco Bilbao Vizcaya Argentaria S.A. increased its stake in shares of Danaher by 51.1% in the 1st quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 46,116 shares of the conglomerate's stock valued at $9,416,000 after buying an additional 15,600 shares during the period. Van Lanschot Kempen Investment Management N.V. increased its stake in shares of Danaher by 0.8% in the 1st quarter. Van Lanschot Kempen Investment Management N.V. now owns 558,202 shares of the conglomerate's stock valued at $114,431,000 after buying an additional 4,640 shares during the period. Berkshire Asset Management LLC PA increased its stake in shares of Danaher by 130.4% in the 1st quarter. Berkshire Asset Management LLC PA now owns 2,995 shares of the conglomerate's stock valued at $584,000 after buying an additional 1,695 shares during the period. Texas Capital Bancshares Inc TX increased its stake in shares of Danaher by 1.7% in the 1st quarter. Texas Capital Bancshares Inc TX now owns 3,714 shares of the conglomerate's stock valued at $761,000 after buying an additional 63 shares during the period. Finally, Texas Capital Bank Wealth Management Services Inc increased its stake in shares of Danaher by 6.1% in the 1st quarter. Texas Capital Bank Wealth Management Services Inc now owns 34,763 shares of the conglomerate's stock valued at $7,126,000 after buying an additional 2,009 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently commented on DHR shares. Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price for the company in a research note on Friday, July 11th. The Goldman Sachs Group reduced their price target on Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft reduced their price target on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Argus reduced their price target on Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. Finally, Barclays restated an "overweight" rating and issued a $225.00 price target (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $247.61.

Danaher Stock Performance

DHR stock opened at $211.2470 on Thursday. The business's 50-day moving average price is $200.46 and its two-hundred day moving average price is $199.62. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The firm has a market cap of $151.26 billion, a PE ratio of 44.95, a P/E/G ratio of 2.96 and a beta of 0.73. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter last year, the business posted $1.72 EPS. The company's revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.